The Role of Continuous Glucose Monitoring in Diabetes Management

An expert endocrine clinical pharmacist shares considerations for the utilization and impact of CGMs in the diabetes treatment landscape.

Role of Continuous Glucose Monitoring (CGM) in Diabetes Management

April 7th 2022

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, reviews the advantages of CGMs in treating type 1 and type 2 diabetes and how CGMs can improve glycemic control and quality of life in patients.

Patient Selection for CGMs in Diabetes

April 7th 2022

Dr Diana Isaacs provides insight on patient factors to consider for CGM use in diabetes treatment.

Utilizing CGMs for Diabetes Management in COVID-19

April 7th 2022

An expert in diabetes management discusses the role of CGMs in treating diabetes during the COVID-19 pandemic and the benefits of using CGM in telemedicine.

Evolution of CGMs in Managing Diabetes

April 14th 2022

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, comments on the accuracy and selection of CGMs in treating diabetes and shares insight on the evolution of CGM systems over the past year.

Emerging CGM Systems in Diabetes Management

April 14th 2022

Dr Diana Isaacs reviews the significance of Eversense’s recent approval for a 180-day indication and the potential role of Dexcom G7 in the diabetes treatment landscape.

Future CGM Advancements for Diabetes Management

April 21st 2022

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, evaluates upcoming CGM advances in the pipeline for the management of diabetes.

Unmet Needs in Diabetes Management

April 21st 2022

Dr Diana Isaacs provides insight on current challenges in the clinical treatment of patients with diabetes and shares clinical pearls for the use of CGMs in disease management.